The Latest Breaking News from Vaccine

The only Lyme disease vaccine previously marketed in the U.S. was discontinued in 2002.

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

When UK authorities granted permission in October 2020 for the first controlled infection study to be carried out to test the anti-Covid-19 vaccine Oxford University had just developed, reactions ranged from disbelief to disapproval.

Monkeypox cases across the UK are on the rise. Amidst World Health Organisation concerns, Public Health Scotland's vaccine program is getting under way despite limited global supply.

LOS ANGELES — As Kelechi Kalu books gigs as a musician, he wonders whether he is putting himself at risk for monkeypox.

BioNTech, which teamed with Pfizer to develop the first widely used COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

COVID-19 complications are more of an issue for adolescents and young adults than the rare side-effect of myocarditis from mRNA virus vaccines, experts say.

There's always a first time for everyone. After three years of living life virus free, I got Covid-19 from a friend after attending a concert recently. However, to my surprise, my first experience wasn't all that terrible. I felt mildly ill, with fever and body aches, but no sore throat…